DOCSLIB.ORG

2018 SIR Annual Scientific Meeting Faculty Financial Disclosures

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
2018 SIR Annual Scientific Meeting Faculty Financial Disclosures 2018 SIR Annual Scientific Meeting Faculty Financial Disclosures Mohamed H.K. Abdelmaksoud Other: Proctor; Consultant: SIRTEX, Merit Medical Inc.; Advisory committee or review panel member: Merit medical Inc. J. Fritz Angle Consultant: Proteon, Dahchi Sankyo; Research grant recipient: Siemens Medical Hussein Aoun Consultant: BTG Medical Yasuaki Arai Royalties: Piolax Medical Devices, Sumitomo Bakelite Co., Ltd; Research grant recipient: Terumo Corporation,Toshiba Medical Systems, Taiho Pharmaceutical, Eisai Co., Ltd.; Advisory committee or review panel member: Eisai Inc; Speaking and teaching: Merit Medical Systems, Fuji Pharma Co., Ltd. ,Terumo International Systems, Nippon Kayaku, Toshiba Medical Systems, Bristol Meyer Squibb, Sumitomo Bakelite Co., Ltd., Bayer Pharmaceuticals, Boston Scientific Japan, Taiho Pharmaceutical, Guerbet Japan, Guerbet Asia Pacific Aravind Arepally Intellectual property rights: Surefire Medical; Consultant: SirTex Medical Bulent Arslan Advisory committee or review panel member: Medtronic; Speaking and teaching: Medtronic, Boston Scientific, Cook, Penumbra Jung Hwan Baek Consultant: STARmed (2017-2018), RF medical (2017 only) Sandeep Bagla Consultant: Medtronic, Boston Scientific, Teleflex, Terumo, Merit; Research grant recipient: Medtronic, Boston Scientific, Terumo, BTG, Renovo Giacomo Basadonna Board membership: Alira Health Douglas Beall Consultant: Benvenue, Lilly, Amendia, Medtronic; Speaking and teaching: Benvenue, Lilly, Medtronic; Board membership: SIR, Vexim, Lilly, Amendia, Medtronic; Ownership interest: Vexim, Lilly, Amendia, Medtronic, Benvenue; Contracted research: Lilly, Amendia, Medtronic George Behrens Speaking and teaching: Penumbra, Carefusion, AngioDynamics; Consultant: Penumbra, Carefusion, AngioDynamics James Benenati Consultant: Merit, Bard, Cardinal Health, WL Gore; Royalties: Penumbra; Other: XableCath, Covidien, Elsiver Shivank Bhatia Consultant: Merit Medical, Terumo Medical, Mentice Inc.; Speaking and teaching - Merit Medical, Medtronic Franz Boas Ownership interest: Claripacs, Labdoor, Qventus, CloudMedx, Notable Labs; Other: Received research supplies from Bayer (sorafenib); Intellectual property rights: US patent 8233586 Francisco Carnevale Royalties: Merit Medical Systems Inc Julius Chapiro Consultant: Guerbet, Philips, Eisai; Research grant recipient: Guerbet, Philips, Boston Scientific, NIH, Rolf W Günther Foundation, German-Israeli Foundation for Research and Development Timothy Clark Royalties: Teleflex, Merit; Consultant: Teleflex, Bard, Merit Jeremy Collins Advisory committee or review panel member: Guerbet; Research grant recipient: Siemens Medical Systems Miles Conrad Other: Medtronic; Consultant: Medtronic Michael Dake Consultant: Cook Medical Novate Medical; Advisory committee or review panel member: W.L. Gore Kush Desai Speaking and teaching: Cook Medical, Boston Scientific, Angiodynamics; Consultant: Spectranetics Mitchell Eggers Salaried employee: Adient Medical; Management position: Adient Medical; Board membership: Adient Medical; Ownership interest: Adient Medical Mary Beth Farrell Salaried employee: Intersocietal Accreditation Commission Khashayar Farsad Consultant: Cook Medical; Speaking and teaching: Neuwave Medical; Advisory committee or review panel member: Bayer Hector Ferral Consultant: Terumo, W.L. Gore; Speaking and teaching: BTG, B&D Laura Findeiss Speaking and teaching: Bayer Pharmaceutical Aloke Finn Speaking and teaching: 480 Biomedical, Abbott Vascular, Boston Scientific, Cordis J&J, Lutonix, Medtronic, Merck, Terumo Corporation, W.L. Gore; Consultant: 480 Biomedical, Abbott Vascular, Medtronic, W.L. Gore; Contracted research: 480 Biomedical, Abbott Vascular, Atrium,BioSensors International, Biotronik, Boston Scientific, Cordis J&J, GSK, Kona, Medtronic, MicroPort Medical, CeloNova, OrbusNeich Medical, ReCore,SINO Medical Technology, Terumo Corporation Ron Gaba Research grant recipient: Guerbet LLC Terence Gade Research grant recipient: Guerbet LLC Ripal Gandhi Consultant: BTG, Merit, Sirtex, Medtronic, Gore, Bard Afshin Gangi Other: Proctoring Galil Medical BTG Suvranu Ganguli Consultant: Sirtex, Boston Scientific, Medtronic; Advisory committee or review panel member: Instylla Mark Garcia Contracted research: EKOS/BTGBoston Scientific; Speaking and teaching: BTG/EKOS, Boston Scientific, Philips/Volcano; Royalties: Merit MedicalIntellectual property rights; Advisory committee or review panel member: Cook MedicalBoston ScientificPhilips/Volcano Ben George Consultant: Celgene, Cook Medical, Merrimack, Ipsen, Foundation Medicine, BMS Kathleen Gibson Consultant: Medtronic, BTG; Contracted research: Medtronic, Angiodynamics, Vascular Insights, Bard; Advisory committee or review panel member: Medtronic; Speaking and teaching: Medtronic, BMS Gerard Goh Consultant: Bard Medical, Cook Medical, Abbott; Advisory committee or review panel member: Siemens Marcelo Guimaraes Intellectual property rights: Cook Medical; Consultant: Terumo Medical Systems, Medtronic, Boston Scientific, Baylis Medical, Guerbet Ziv Haskal Contracted research: Siemens, Sequana, Teclison; Consultant: CR Bard, WL Gore and Associates, Fluidx, Bendit, Medtronic, Boston Scientific Lawrence Hofmann Royalties: Cook Medical; Consultant: Cook Medical; Ownership interest: Grand Rounds Kelvin Hong Advisory committee or review panel member: BTG, Boston Scientific; Research grant recipient: Merit Medical Masahiro Horikawa Consultant: Shimadzu Medical System, Terumo Inc., Tokai Medical Products Albert Hsiao Research grant recipient: GE Healthcare; Other: Founder and Consultant, Arterys, Inc Maxim Itkin Speaking and teaching: Guerbert Group; Research grant recipient: Guerbert Group Jack W Jennings Consultant: Merit, Medtronic, Bard; Speaking and teaching: Merit; Advisory committee or review panel member: Merit and Medtronic Matthew Johnson Contracted research: PI of PRESERVE: Supported by companies which work with SIR; funds managed by the IVC Filter Foundation. Companies with support PRESERVE are: ALN,Argon, B Braun, Bard, Cook, Cordis/Cardinal Health; Contracted research: BTG, NovateSurefire, Avantec, Bayer, Boston Scientific, BMS, BTG, Cook, Johnson & Johnson, Surefire; Ownership interest: Endoshape (stockholder) William Julien Speaking and teaching: CSI, Abbott, Cook; Contracted research: BSCI, Rex Medical; Advisory committee or review panel member - Philips Sanjeeva Kalva Royalties: Springer, Elsevier; Consultant: GE, Koo Foundation; Ownership interest: Althea Healthcare Alexis Kelekis Speaking and teaching: Medtronic, Toshiba, Mindray Eric Keller Ownership interest: CEO & Founder of HuNamics, LLC Edward Kim Advisory committee or review panel member: Boston Scientific, BTG, Bristol Myers Squibb, Johnson and Johnson, Neuwave; Ownership interest: Accurate Medical Charles Kim Consultant: Galvani, Medtronic, Bard; Advisory committee or review panel member: Humacyte Maureen Kohi Advisory committee or review panel member: Abbvie; Consultant: LaForceSirtex; Speaking and teaching: Argon Kenneth Kolbeck Speaking and teaching: Guerbet (Lipiodol), Bayer (Sorafenib) Nishita Kothary Advisory committee or review panel member: Scientific Advisor, Siemens Healthcare Echopixel Inc A. Kurup Research grant recipient: Galil Medical; Royalties: UpToDate, Inc. Elvira Lang Ownership interest: Hypnalgesics, LLC d/b/a Comfort Talk® Riccardo Lencioni Consultant: BTG, Guerbet, Bayer Lindsay Machan Advisory committee or review panel member: Boston Scientific; Ownership interest: A4L, Calgary Scientific, Harmonic Medical, Innovere Medical, Confluent Medical, Zymeworks; Board membership: Ikomed Medical Stefano Marcia Consultant: Spineart, Vexim, Techlamed Alan Matsumoto Research grant recipient: WL Gore, Medtronic, Insightec, Cook; Advisory committee or review panel member: Bolton Medical, WL Gore, Boston Scientific, Tenex Medical, Brightwater, Siemens, Proteon Endologix; Other: Volcano Medical - Stockholder Giovanni Mauri Consultant: Elesta SrL; Speaking and teaching: Guerbet Gordon McLennan Advisory committee or review panel member: Rene Medical, Siemens, GE, Stealth Medical, Surefire, B Braun, Roche, Bristol Myers Squibb; Speaking and teaching: Medtronic, Guerbet Sanjay Misra Research grant recipient: NIH Gregory Nadolski Research grant recipient: Guerbet LLC, Teleflex; Consultant: Teleflex Govindarajan Narayanan Consultant: Angiodynamics, BTG,Siemens, J&J Neuwave, Galil, Medtronic Kari Nelson Contracted research: Philips Medical CRADA, Teclison Limited, Sillajen Franco Orsi Advisory committee or review panel member: River Global Group; Speaking and teaching: Medtronic Dustin Osborne Contracted research: Biocompatibles Rahul Patel Consultant: Medtronic Inc, Sirtex Medical; Speaking and teaching: Terumo MedicalPenumbra Inc Constantino Pena Consultant: Boston Scientific; Speaking and teaching: Cook medical, CR Bard, Halyard, Penumbra; Advisory committee or review panel member: CR Bard; Ownership interest: Bright water Medical Wyatt Potter Salaried employee: Novocure with stock options J. David Prologo Research grant recipient: Galil Medical, Healthtronics, Cook; Consultant: Galil Medical, Merit Medical Dheeraj Rajan Ownership interest: TVA Medical Paul Rochon Speaking and teaching: BARD, Penumbra Wael Saad Speaking and teaching: GORE; Consultant: Medtronic, GORE, Siemens Sharjeel Sabir Other: Ethicon Saher Sabri Advisory committee or review panel member: Medtronic; Speaking and teaching: W.L. Gore Riad Salem Contracted research: BTG; Consultant: BTG, Merit, Boston Scientific, Exelixis, Eisai Sudhakar Satti
Load more

Recommended publications
  • Jefferies 2013 Global Healthcare Conference in London
    Jefferies 2013 Global Healthcare Conference in London At the 2012 Jefferies Global Healthcare Conference, there were well over 200 healthcare companies participating with a combined market cap of $1 trillion and close to 1,300 one-on-one/small group meetings over the two-day event. The 2013 conference is set to follow the same footsteps, featuring public and private leading INVITATION global healthcare companies within the areas of pharmaceuticals, biotech, generics, 20-21 NOVEMBER 2013 medtech and healthcare services from the US, Central and Eastern Europe, Latin The Waldorf Hilton America, India, China, Japan, Egypt, Israel and Russia. London, UK Throughout the two-day event, we will feature concurrent tracks of informative presentations as well as 1x1/small group meetings, and thematic panel discussions. This global gathering of institutional investors, private equity investors, VCs and leading executives will address near- and long-term investment opportunities and discuss the mechanisms driving global healthcare. We hope you can join us for what promises to be a unique and comprehensive view of the industry. Registration is now open. Please email your Jefferies representative if you are interested in attending. For general questions, please email [email protected] or contact your Jefferies representative. © 2013 Jefferies LLC. Member SIPC. AGENDA WEDNESDAY, 20 NOVEMBER 2013 Jefferies 2013 Global Healthcare Conference in London ADELPHI 1 ADELPHI 2 ADELPHI 3 EXECUTIVE BOARDROOM 7:30 AM Breakfast & Registration 8:00 AM Clinigen Group Plc Ion Beam Applications Active Biotech AB Syneron Medical Ltd. Specialty Pharma & Healthcare Services Medical Products Biotechnology Medical Technology Paul Thomas; CTO Olivier Legrain, CEO Tomas Leanderson; President and CEO Hugo Goldman, CFO 8:40 AM Valneva Celltrion, Inc.
    [Show full text]
  • Retirement Strategy Fund 2060 Description Plan 3S DCP & JRA
    Retirement Strategy Fund 2060 June 30, 2020 Note: Numbers may not always add up due to rounding. % Invested For Each Plan Description Plan 3s DCP & JRA ACTIVIA PROPERTIES INC REIT 0.0137% 0.0137% AEON REIT INVESTMENT CORP REIT 0.0195% 0.0195% ALEXANDER + BALDWIN INC REIT 0.0118% 0.0118% ALEXANDRIA REAL ESTATE EQUIT REIT USD.01 0.0585% 0.0585% ALLIANCEBERNSTEIN GOVT STIF SSC FUND 64BA AGIS 587 0.0329% 0.0329% ALLIED PROPERTIES REAL ESTAT REIT 0.0219% 0.0219% AMERICAN CAMPUS COMMUNITIES REIT USD.01 0.0277% 0.0277% AMERICAN HOMES 4 RENT A REIT USD.01 0.0396% 0.0396% AMERICOLD REALTY TRUST REIT USD.01 0.0427% 0.0427% ARMADA HOFFLER PROPERTIES IN REIT USD.01 0.0124% 0.0124% AROUNDTOWN SA COMMON STOCK EUR.01 0.0248% 0.0248% ASSURA PLC REIT GBP.1 0.0319% 0.0319% AUSTRALIAN DOLLAR 0.0061% 0.0061% AZRIELI GROUP LTD COMMON STOCK ILS.1 0.0101% 0.0101% BLUEROCK RESIDENTIAL GROWTH REIT USD.01 0.0102% 0.0102% BOSTON PROPERTIES INC REIT USD.01 0.0580% 0.0580% BRAZILIAN REAL 0.0000% 0.0000% BRIXMOR PROPERTY GROUP INC REIT USD.01 0.0418% 0.0418% CA IMMOBILIEN ANLAGEN AG COMMON STOCK 0.0191% 0.0191% CAMDEN PROPERTY TRUST REIT USD.01 0.0394% 0.0394% CANADIAN DOLLAR 0.0005% 0.0005% CAPITALAND COMMERCIAL TRUST REIT 0.0228% 0.0228% CIFI HOLDINGS GROUP CO LTD COMMON STOCK HKD.1 0.0105% 0.0105% CITY DEVELOPMENTS LTD COMMON STOCK 0.0129% 0.0129% CK ASSET HOLDINGS LTD COMMON STOCK HKD1.0 0.0378% 0.0378% COMFORIA RESIDENTIAL REIT IN REIT 0.0328% 0.0328% COUSINS PROPERTIES INC REIT USD1.0 0.0403% 0.0403% CUBESMART REIT USD.01 0.0359% 0.0359% DAIWA OFFICE INVESTMENT
    [Show full text]
  • May 11, 2011 Company Name: Terumo Corporation Representative: Yutaro Shintaku, President Code No.: 4543, TSE Section 1 Inquirie
    May 11, 2011 Company name: Terumo Corporation Representative: Yutaro Shintaku, President Code No.: 4543, TSE Section 1 Inquiries: Tetsuya Kumei, General Manager, Corporate Communication / IR Dept. Notice Concerning the Renewal of a Policy for Large-scale Acquisitions of Terumo Shares (Takeover Defense Measures) In the Board of Directors held on April 30, 2008, Terumo Corporation decided upon the Company’s basic policy regarding those who control decisions on the Company’s financial and business policies. Giving consideration to this policy, the Company also decided upon introduction of policy for large-scale acquisitions of the Company’s shares (hereinafter referred to as the “Current Plan”) as a means to prevent decisions on the Company’s financial and business policies from being controlled by an inappropriate party. The Current Plan was approved by shareholders in the 93rd Annual General Meeting of Shareholders held on June 27, 2008. The effective period of the Current Plan is until the conclusion of the final Annual General Meeting of Shareholders in the business year ending no more than three years from the time of the conclusion of the 93rd Annual General Meeting of Shareholders. Based on consideration of recent trends in debate on takeover defense measures including amendments of the law since the Current Plan was implemented and the Corporate Value Study Group established by the Ministry of Economy, Trade and Industry, the Company reaffirmed that the current policy should be maintained in the Board of Directors held on May 11, 2011, and passed a resolution to make revisions to the Current Plan required by amendments to the law (the revised plan is hereinafter referred to as the “Plan”) and renew the Current Plan in the form of the Plan as a means to prevent decisions on the Company’s financial and business policies from being controlled by an inappropriate party.
    [Show full text]
  • FTSE Japan ESG Low Carbon Select
    2 FTSE Russell Publications 19 August 2021 FTSE Japan ESG Low Carbon Select Indicative Index Weight Data as at Closing on 30 June 2021 Constituent Index weight (%) Country Constituent Index weight (%) Country Constituent Index weight (%) Country ABC-Mart 0.01 JAPAN Ebara 0.17 JAPAN JFE Holdings 0.04 JAPAN Acom 0.02 JAPAN Eisai 1.03 JAPAN JGC Corp 0.02 JAPAN Activia Properties 0.01 JAPAN Eneos Holdings 0.05 JAPAN JSR Corp 0.11 JAPAN Advance Residence Investment 0.01 JAPAN Ezaki Glico 0.01 JAPAN JTEKT 0.07 JAPAN Advantest Corp 0.53 JAPAN Fancl Corp 0.03 JAPAN Justsystems 0.01 JAPAN Aeon 0.61 JAPAN Fanuc 0.87 JAPAN Kagome 0.02 JAPAN AEON Financial Service 0.01 JAPAN Fast Retailing 3.13 JAPAN Kajima Corp 0.1 JAPAN Aeon Mall 0.01 JAPAN FP Corporation 0.04 JAPAN Kakaku.com Inc. 0.05 JAPAN AGC 0.06 JAPAN Fuji Electric 0.18 JAPAN Kaken Pharmaceutical 0.01 JAPAN Aica Kogyo 0.07 JAPAN Fuji Oil Holdings 0.01 JAPAN Kamigumi 0.01 JAPAN Ain Pharmaciez <0.005 JAPAN FUJIFILM Holdings 1.05 JAPAN Kaneka Corp 0.01 JAPAN Air Water 0.01 JAPAN Fujitsu 2.04 JAPAN Kansai Paint 0.05 JAPAN Aisin Seiki Co 0.31 JAPAN Fujitsu General 0.01 JAPAN Kao 1.38 JAPAN Ajinomoto Co 0.27 JAPAN Fukuoka Financial Group 0.01 JAPAN KDDI Corp 2.22 JAPAN Alfresa Holdings 0.01 JAPAN Fukuyama Transporting 0.01 JAPAN Keihan Holdings 0.02 JAPAN Alps Alpine 0.04 JAPAN Furukawa Electric 0.03 JAPAN Keikyu Corporation 0.02 JAPAN Amada 0.01 JAPAN Fuyo General Lease 0.08 JAPAN Keio Corp 0.04 JAPAN Amano Corp 0.01 JAPAN GLP J-REIT 0.02 JAPAN Keisei Electric Railway 0.03 JAPAN ANA Holdings 0.02 JAPAN GMO Internet 0.01 JAPAN Kenedix Office Investment Corporation 0.01 JAPAN Anritsu 0.15 JAPAN GMO Payment Gateway 0.01 JAPAN KEWPIE Corporation 0.03 JAPAN Aozora Bank 0.02 JAPAN Goldwin 0.01 JAPAN Keyence Corp 0.42 JAPAN As One 0.01 JAPAN GS Yuasa Corp 0.03 JAPAN Kikkoman 0.25 JAPAN Asahi Group Holdings 0.5 JAPAN GungHo Online Entertainment 0.01 JAPAN Kinden <0.005 JAPAN Asahi Intecc 0.01 JAPAN Gunma Bank 0.01 JAPAN Kintetsu 0.03 JAPAN Asahi Kasei Corporation 0.26 JAPAN H.U.
    [Show full text]
  • JPX-Nikkei Index 400 Constituents (Applied on August 31, 2021) Published on August 6, 2021 No
    JPX-Nikkei Index 400 Constituents (applied on August 31, 2021) Published on August 6, 2021 No. of constituents : 400 (Note) The No. of constituents is subject to change due to de-listing. etc. (Note) As for the market division, "1"=1st section, "2"=2nd section, "M"=Mothers, "J"=JASDAQ. Code Market Divison Issue Code Market Divison Issue 1332 1 Nippon Suisan Kaisha,Ltd. 3048 1 BIC CAMERA INC. 1417 1 MIRAIT Holdings Corporation 3064 1 MonotaRO Co.,Ltd. 1605 1 INPEX CORPORATION 3088 1 Matsumotokiyoshi Holdings Co.,Ltd. 1719 1 HAZAMA ANDO CORPORATION 3092 1 ZOZO,Inc. 1720 1 TOKYU CONSTRUCTION CO., LTD. 3107 1 Daiwabo Holdings Co.,Ltd. 1721 1 COMSYS Holdings Corporation 3116 1 TOYOTA BOSHOKU CORPORATION 1766 1 TOKEN CORPORATION 3141 1 WELCIA HOLDINGS CO.,LTD. 1801 1 TAISEI CORPORATION 3148 1 CREATE SD HOLDINGS CO.,LTD. 1802 1 OBAYASHI CORPORATION 3167 1 TOKAI Holdings Corporation 1803 1 SHIMIZU CORPORATION 3231 1 Nomura Real Estate Holdings,Inc. 1808 1 HASEKO Corporation 3244 1 Samty Co.,Ltd. 1812 1 KAJIMA CORPORATION 3254 1 PRESSANCE CORPORATION 1820 1 Nishimatsu Construction Co.,Ltd. 3288 1 Open House Co.,Ltd. 1821 1 Sumitomo Mitsui Construction Co., Ltd. 3289 1 Tokyu Fudosan Holdings Corporation 1824 1 MAEDA CORPORATION 3291 1 Iida Group Holdings Co.,Ltd. 1860 1 TODA CORPORATION 3349 1 COSMOS Pharmaceutical Corporation 1861 1 Kumagai Gumi Co.,Ltd. 3360 1 SHIP HEALTHCARE HOLDINGS,INC. 1878 1 DAITO TRUST CONSTRUCTION CO.,LTD. 3382 1 Seven & I Holdings Co.,Ltd. 1881 1 NIPPO CORPORATION 3391 1 TSURUHA HOLDINGS INC. 1893 1 PENTA-OCEAN CONSTRUCTION CO.,LTD.
    [Show full text]
  • TOBAM Maximum Diversification All World Developed Ex North America USD
    TOBAM Maximum Diversification All World Developed ex North America USD 31/12/2019 Instrument Weight BP PLC 0.10% IDEMITSU KOSAN CO LTD 0.21% INPEX HOLDINGS INC 0.07% JX HOLDINGS INC 0.09% NESTE OIL OYJ 1.16% OMV AG 0.08% SANTOS LTD 0.02% SBM OFFSHORE NV 0.05% TGS NOPEC GEOPHYSICAL CO ASA 0.02% VOPAK 0.02% WOOD GROUP (JOHN) PLC 0.02% AIR LIQUIDE 0.23% AIR WATER INC 0.02% AKZO NOBEL 0.12% ALUMINA LTD 0.03% AMCOR PLC-CDI 0.08% AVON RESOURCES LTD 0.53% BORAL LTD 0.02% CHR HANSEN HOLDING A/S 0.08% DAICEL CHEMICAL INDUSTRIES 0.02% DOWA HOLDINGS CO LTD 0.01% EMS-CHEMIE HOLDING AG-REG 0.03% FLETCHER BUILDING LTD 0.02% FORTESCUE METALS GROUP LTD 0.60% GIVAUDAN-REG 0.16% HITACHI CHEMICAL CO LTD 0.03% HUHTAMAKI OYJ 0.03% ISRAEL CHEMICALS LTD 0.02% JAMES HARDIE INDUSTRIES-CDI 0.07% JFE HOLDINGS INC 0.02% KANSAI PAINT CO LTD 0.03% KURARAY CO LTD 0.03% MITSUBISHI MATERIALS CORP 0.02% NEWCREST MINING LTD 1.35% TOBAM Maximum Diversification All World Developed ex North America USD 31/12/2019 Instrument Weight NIPPON PAINT CO LTD 0.05% NIPPON PAPER INDUSTRIES CO L 0.04% NIPPON SHOKUBAI CO LTD 0.01% NISSAN CHEMICAL INDUSTRIES 0.04% NOF CORP 0.02% NORTHERN STAR RESOURCES LTD 0.66% NOVOZYMES A/S-B SHARES 0.07% OJI PAPER CO LTD 0.03% ORICA LTD 0.02% ORORA LTD 0.02% SARACEN MINERAL HOLDINGS LTD 0.32% SMURFIT KAPPA GROUP PLC 0.04% SYMRISE AG 0.04% TAIHEIYO CEMENT CORP 0.02% TAIYO NIPPON SANSO CORP 0.02% TEIJIN LTD 0.02% THYSSENKRUPP AG 0.04% TORAY INDUSTRIES INC 0.02% WIENERBERGER AG 0.02% ADP 0.04% AENA SA 0.09% ALFA LAVAL AB 0.04% ALL NIPPON AIRWAYS CO LTD
    [Show full text]
  • Misinterpretation of Time-To-First Event Curves Can Lead to Inappropriate Treatment
    AGORA | CORRESPONDENCE Misinterpretation of time-to-first event curves can lead to inappropriate treatment To the Editor: Great care should be taken when assessing the consistency of treatment effect over time based on a survival curve plot, and even more so when a treatment affects a repeating event end-point, such as exacerbations, rather than an event that can occur only once, like death. In their recent editorial in the European Respiratory Journal,SUISSA and ARIEL [1] make the assertation that survival functions plotted from Kaplan–Meier estimates from figure 1b in the IMPACT study [2] “clearly show that the difference in the rate of exacerbation between LAMA/LABA/ICS and LAMA/LABA over follow-up is due to the first month’s surge, with practically no differences in the subsequent rates between the two groups”. However, this statement is based on a misunderstanding of the survival analyses presented. The events plotted on the figure are the first moderate or severe COPD exacerbations experienced by a patient in the IMPACT study. The statements made by SUISSA and ARIEL [1] about exacerbation rates refer to the rate of first exacerbations only, and not to the rate of all exacerbations during the study. Their conclusion that the rates of first exacerbations, and ratio between those rates changes over time is correct. However, this is entirely in line with statistical theory for repeated events with overall constant rates. It cannot be used to support any conclusion that the difference in the rate of exacerbation is due to a “first month’s surge”. The “digitised” curve of first events behaves entirely consistently with constant rate events.
    [Show full text]
  • Istoxx® Mutb Japan Momentum 300 Index
    ISTOXX® MUTB JAPAN MOMENTUM 300 INDEX Components1 Company Supersector Country Weight (%) Z HOLDINGS Technology Japan 0.69 M3 Health Care Japan 0.65 KOEI TECMO HOLDINGS Technology Japan 0.65 MENICON Health Care Japan 0.59 CAPCOM Technology Japan 0.58 FUJITEC Industrial Goods & Services Japan 0.56 Ibiden Co. Ltd. Industrial Goods & Services Japan 0.56 NIPPON PAINT HOLDINGS Chemicals Japan 0.56 RENESAS ELECTRONICS Technology Japan 0.55 JEOL Industrial Goods & Services Japan 0.55 INTERNET INTV.JAPAN Technology Japan 0.53 JSR Corp. Chemicals Japan 0.52 NET ONE SYSTEMS Technology Japan 0.51 Fujitsu Ltd. Technology Japan 0.51 Bank of Kyoto Ltd. Banks Japan 0.51 Hokuhoku Financial Group Inc. Banks Japan 0.51 FUJITSU GENERAL Personal & Household Goods Japan 0.50 Iyo Bank Ltd. Banks Japan 0.50 Kyushu Financial Group Banks Japan 0.50 77 Bank Ltd. Banks Japan 0.49 COCOKARA FINE INC. Retail Japan 0.49 TOSHIBA TEC Industrial Goods & Services Japan 0.48 JCR PHARMACEUTICALS Health Care Japan 0.48 MONOTARO Retail Japan 0.48 COSMOS PHARM. Retail Japan 0.48 Tokyo Electron Ltd. Technology Japan 0.48 Nomura Research Institute Ltd. Technology Japan 0.48 Olympus Corp. Health Care Japan 0.47 SUNDRUG Retail Japan 0.47 Chiba Bank Ltd. Banks Japan 0.47 NEC NETWORKS & SY.INTG. Technology Japan 0.47 Nomura Holdings Inc. Financial Services Japan 0.47 TOKYO OHKA KOGYO Technology Japan 0.47 PENTA-OCEAN CONSTRUCTION Construction & Materials Japan 0.47 FUYO GENERAL LEASE Financial Services Japan 0.46 FUJI Industrial Goods & Services Japan 0.46 Hachijuni Bank Ltd.
    [Show full text]
  • International Smallcap Separate Account As of July 31, 2017
    International SmallCap Separate Account As of July 31, 2017 SCHEDULE OF INVESTMENTS MARKET % OF SECURITY SHARES VALUE ASSETS AUSTRALIA INVESTA OFFICE FUND 2,473,742 $ 8,969,266 0.47% DOWNER EDI LTD 1,537,965 $ 7,812,219 0.41% ALUMINA LTD 4,980,762 $ 7,549,549 0.39% BLUESCOPE STEEL LTD 677,708 $ 7,124,620 0.37% SEVEN GROUP HOLDINGS LTD 681,258 $ 6,506,423 0.34% NORTHERN STAR RESOURCES LTD 995,867 $ 3,520,779 0.18% DOWNER EDI LTD 119,088 $ 604,917 0.03% TABCORP HOLDINGS LTD 162,980 $ 543,462 0.03% CENTAMIN EGYPT LTD 240,680 $ 527,481 0.03% ORORA LTD 234,345 $ 516,380 0.03% ANSELL LTD 28,800 $ 504,978 0.03% ILUKA RESOURCES LTD 67,000 $ 482,693 0.03% NIB HOLDINGS LTD 99,941 $ 458,176 0.02% JB HI-FI LTD 21,914 $ 454,940 0.02% SPARK INFRASTRUCTURE GROUP 214,049 $ 427,642 0.02% SIMS METAL MANAGEMENT LTD 33,123 $ 410,590 0.02% DULUXGROUP LTD 77,229 $ 406,376 0.02% PRIMARY HEALTH CARE LTD 148,843 $ 402,474 0.02% METCASH LTD 191,136 $ 399,917 0.02% IOOF HOLDINGS LTD 48,732 $ 390,666 0.02% OZ MINERALS LTD 57,242 $ 381,763 0.02% WORLEYPARSON LTD 39,819 $ 375,028 0.02% LINK ADMINISTRATION HOLDINGS 60,870 $ 374,480 0.02% CARSALES.COM AU LTD 37,481 $ 369,611 0.02% ADELAIDE BRIGHTON LTD 80,460 $ 361,322 0.02% IRESS LIMITED 33,454 $ 344,683 0.02% QUBE HOLDINGS LTD 152,619 $ 323,777 0.02% GRAINCORP LTD 45,577 $ 317,565 0.02% Not FDIC or NCUA Insured PQ 1041 May Lose Value, Not a Deposit, No Bank or Credit Union Guarantee 07-17 Not Insured by any Federal Government Agency Informational data only.
    [Show full text]
  • JAPANESE INDUSTRY and POLICY NEWS February-March, 2021
    JAPANESE INDUSTRY AND POLICY NEWS February-March, 2021 Legislation and Policy News ⚫ JCM's first credit issuance with Kenya 974 tons in solar power generation business ⚫ Achieves unmanned platooning technology for trucks following trucks on highways ⚫ Government decides to revise the Global Warming Countermeasures Promotion Law by Cabinet decision, "2050 Carbon Neutral" clarified Survey and Business Data ⚫ CO2 concentration near Japan continues to increase, Japan Meteorological Agency Company & Organization News ⚫ J-Power begins production of next-generation energy hydrogen in Australia, Transport to Japan ⚫ Mitsubishi Heavy Industries establishes "MHI Vestas Japan", a sales company for wind power generation equipment ⚫ Japanese "RE100" member companies reached 50, the second largest in the world, but there are challenges in procuring renewable energy ⚫ Completed international hydrogen supply chain demonstration by Chiyoda corporation, etc. Supplying over 100 tons ⚫ TEPCO participates in demonstration of floating wind turbines in Northern Europe, aiming for construction in Japan ⚫ Business alliance with Circularise B.V., introduction of traceability management platform to Asia for building a circular economy ⚫ ITOCHU and Aquafil announce a strategic partnership to support and to expand the nylon circular business ⚫ NYK operates 44 MW wind power generation facility at Belgian finished vehicle terminal ⚫ ITOCHU announced strategic joint venture with Air Liquide on hydrogen value chain development ⚫ Euglena completes bio-jet fuel to fly
    [Show full text]
  • Jefferies 2014 Global Healthcare Conference in London
    Jefferies 2014 Global Healthcare Conference in London You are invited to attend the Jefferies Global Healthcare Conference on 19-20 November, 2014, at the Waldorf Hilton in London. Now in its fifth year, ours is the largest healthcare-dedicated conference in Europe. Last year, we had 230 participating healthcare companies with a combined market capitalisation of over INVITATION $1 trillion and close to 2,250 1x1/small-group meetings. The 2014 conference is set to follow 19-20 NOVEMBER 2014 in the same footsteps, featuring leading public and private companies from areas of The Waldorf Hilton pharmaceuticals, biotechnology, generics, consumer health, animal health, medical London, UK technology and healthcare services from the United States, Western and Emerging Europe, Middle East & Africa, Latin America, Russia, India, Israel, China, and Japan. This global gathering of leading healthcare executives and institutional, private equity and venture capital investors will address near and long-term investment opportunities and discuss the mechanisms driving global healthcare. We hope you can join us for what promises to be a unique and comprehensive view of the industry. Registration is now open. Please email your Jefferies representative if you are interested in attending. For general questions, please email [email protected] or contact your Jefferies representative © 2014 Jefferies LLC. Member SIPC. AGENDA WEDNESDAY, NOVEMBER 19, 2014 Jefferies 2014 Global Healthcare Conference in London TRACK 1 TRACK 2 TRACK 3 TRACK 4 TRACK 5 ADELPHI 1 ADELPHI 2 ADELPHI 3 EXECUTIVE BOARDROOM ALDWYCH 7:30 AM Breakfast and Registration 8:00 AM EMIS Group PLC( AIM:EMIS) Auris Medical Holding AG Sartorius AG (DB:SRT) Medivation, Inc.(NasdaqGS:MDVN) Ethypharm SA (Private) Healthcare Technology (NasdaqGM:EARS) Medical Products & Devices Biotechnology Pharmaceuticals Chris Spencer, CEO Pharmaceuticals Joerg Pfirrmann, CFO David Hung, M.D., President and CEO Hugues Lecat, CEO and Chairman of the Dr.
    [Show full text]
  • TOBAM Maximum Diversification Japan JPY
    TOBAM Maximum Diversification Japan JPY 30/12/2019 Instrument Weight COSMO ENERGY HOLDINGS CO LTD 0.05% IDEMITSU KOSAN CO LTD 0.46% INPEX HOLDINGS INC 0.47% JX HOLDINGS INC 0.35% DAICEL CHEMICAL INDUSTRIES 0.07% DOWA HOLDINGS CO LTD 0.05% HITACHI CHEMICAL CO LTD 0.38% HITACHI METALS LTD 0.05% JSR CORP 0.09% KANSAI PAINT CO LTD 0.14% KOBE STEEL LTD 0.05% MITSUBISHI MATERIALS CORP 0.08% NIPPON KAYAKU CO LTD 0.05% NIPPON PAINT CO LTD 0.23% NIPPON PAPER INDUSTRIES CO L 0.24% NIPPON SHOKUBAI CO LTD 0.18% NISSAN CHEMICAL INDUSTRIES 0.12% NITTO DENKO CORP 0.05% OJI PAPER CO LTD 0.13% SHOWA DENKO K K 0.10% SUMITOMO METAL MINING CO LTD 0.20% TAIHEIYO CEMENT CORP 0.05% TAIYO NIPPON SANSO CORP 0.30% TOKAI CARBON CO LTD 0.93% TORAY INDUSTRIES INC 0.26% TOYO SEIKAN KAISHA LTD 0.07% ALL NIPPON AIRWAYS CO LTD 0.27% CENTRAL JAPAN RAILWAY CO 0.02% COMSYS HOLDINGS CORP 0.09% FANUC LTD 0.38% HINO MOTORS LTD 0.07% HOSHIZAKI CORP 1.50% IHI CORP 0.08% ITOCHU CORP 0.16% TOBAM Maximum Diversification Japan JPY 30/12/2019 Instrument Weight JAPAN AIRLINES CO LTD 0.49% JGC HOLDINGS CORP 0.09% JS GROUP CORP 0.85% KEIHAN ELECTRIC RAILWAY CO 0.13% KEIO CORP 0.18% KINTETSU CORP 0.26% KOMATSU LTD 0.07% KYOWA EXEO CORP 0.06% KYUSHU RAILWAY COMPANY 0.13% MAKITA CORP 0.22% MITSUBISHI CORP 0.69% MITSUBISHI HEAVY INDUSTRIES 0.31% NAGOYA RAILROAD CO LTD 0.14% NANKAI ELECTRIC RAILWAY CO 0.08% OBAYASHI CORP 0.13% ODAKYU ELECTRIC RAILWAY CO 0.20% PARK24 CO LTD 1.15% RECRUIT HOLDINGS CO LTD 0.10% SANKYU INC 0.07% SECOM CO LTD 0.06% SEIBU HOLDINGS INC 0.09% SEINO HOLDINGS CO LTD
    [Show full text]